NCIt definition : An orally available small molecule with potential antineoplastic activity. Quizartinib
selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine
kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell
factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs),
resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis.
Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic
alterations in acute myeloid leukemia (AML) and occur in approximately one-third of
AML cases.;
UNII : 7LA4O6Q0D3;
InChIKey : CVWXJKQAOSCOAB-UHFFFAOYSA-N;
CAS number : 950769-58-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 950769-58-1
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Drug name : Vanflyta;
Molecule name : AC-220; AC010220; ASP-2689; ASP 2689;